Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial.
Bom LeeByeong-Keuk KimByeong-Keuk KimYong-Joon LeeSung Jin HongChul-Min AhnJung-Sun KimYoung-Guk KoDoonghoon ChoiMeyong-Ki HongYang Soo JangPublished in: Arteriosclerosis, thrombosis, and vascular biology (2023)
After percutaneous coronary intervention for acute coronary syndrome, women demonstrated worse clinical outcomes than men. Ticagrelor monotherapy after 3-month dual-antiplatelet therapy was associated with significantly lower risk of net adverse clinical events in women without sex interaction.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- polycystic ovary syndrome
- coronary artery disease
- coronary artery bypass grafting
- pregnancy outcomes
- coronary artery bypass
- cervical cancer screening
- insulin resistance
- breast cancer risk
- middle aged
- low dose
- heart failure
- open label
- combination therapy
- randomized controlled trial
- pregnant women
- emergency department
- stem cells
- type diabetes
- cardiovascular events
- glycemic control
- adipose tissue
- atrial fibrillation
- anti inflammatory drugs